Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Nephrology

The Role of the Kidney Biopsy and Pathology

At a Glance

Immunotactoid glomerulopathy is confirmed through a kidney biopsy that combines light microscopy, immune staining, and electron microscopy. Hollow, organized microtubule deposits, along with supporting test results, help distinguish ITG from fibrillary disease and amyloidosis.

While blood and urine tests can suggest that your kidneys are struggling, a kidney biopsy is the only way to definitively diagnose Immunotactoid Glomerulopathy (ITG) [1]. In this procedure, a small sample of kidney tissue is removed and analyzed by a specialist called a renal pathologist.

Because ITG is so rare, the diagnosis requires a highly detailed look at your tissue using three different types of microscopy. Your pathology report is like a forensic file; each section provides a different piece of the puzzle.

The Three Pillars of Your Pathology Report

A complete diagnosis of ITG must include findings from three distinct tests performed on your biopsy sample, assuming sufficient tissue was obtained:

1. Light Microscopy (The “Standard” View)

Under a standard microscope, ITG does not have a single “look.” It may appear as different types of inflammation or scarring, such as a membranoproliferative or membranous pattern [1][2]. Because these patterns can be seen in many other kidney diseases, light microscopy alone cannot confirm ITG.

2. Immunofluorescence (The “Glow” Test)

In this test, the pathologist uses fluorescent dyes to see which proteins are stuck in your kidney.

  • IgG Dominance: Most ITG cases show strong staining for IgG, a type of antibody [1].
  • Light-Chain Restriction: The pathologist will look at two proteins called Kappa and Lambda. If only one of these is predominantly present (restriction), it suggests the protein is monoclonal, meaning it is being produced by a single “clone” of abnormal cells [1][3]. About 67% of ITG cases in one series showed this restriction [1].
  • Complement: Deposits of C3 or other complement proteins (part of the immune system’s alarm) are also commonly seen [1].

3. Electron Microscopy (The Definitive View)

This is the most critical part of the report. Using a microscope that can see objects at the molecular level, the pathologist looks for the hallmark of ITG: microtubules (extracellular protein deposits, not normal cellular structures) [1].

  • Hollow Centers: Unlike other diseases where proteins form solid clumps, ITG proteins form hollow, straw-like pipes [1][4].
  • Size: These microtubules are typically between 14 and 60 nanometers (nm) in diameter [1][3].
  • Organization: These “pipes” are often stacked neatly in parallel arrays, like a box of drinking straws [1].

Telling ITG Apart from Similar Diseases

Because several rare diseases involve protein deposits, pathologists must use specific “tie-breaker” tests to ensure they don’t misdiagnose you. These stains argue against look-alike conditions but must be interpreted together.

Feature Immunotactoid (ITG) Fibrillary (FGN) Amyloidosis
Structure Hollow Microtubules [1] Solid Fibrils [4] Solid Fibrils [5]
Arrangement Organized/Parallel [1] Random/Disorganized [4] Random/Disorganized [5]
Diameter 14–60 nm (Larger) [1] <30 nm (Smaller) [6] ~10 nm (Smallest) [5]
Congo Red Stain Negative [1] Negative [4] Positive [5]
DNAJB9 Test Negative [6] Positive [6] Negative

Cryoglobulinemic Glomerulonephritis is another look-alike. It can also form microtubules, but doctors distinguish it by testing your blood for cryoglobulins (proteins that clump in the cold) and checking for specific patterns inside the kidney’s blood vessels [5][7].

Your Diagnostic Checklist

When you review your pathology report, ensure it addresses these specific points. If any are missing, it may be worth asking your doctor if a second opinion from a specialized renal pathologist is needed.

  • [ ] Electron Microscopy (EM): Were hollow microtubules seen? What was their diameter and arrangement?
  • [ ] Parallel Arrays: Were the structures organized or random?
  • [ ] Congo Red: Was it negative? (Argues strongly against amyloidosis) [1].
  • [ ] DNAJB9 Status: Was this test performed and was it negative? (Argues strongly against FGN) [6].
  • [ ] Monoclonal vs. Polyclonal: Does the immunofluorescence (IF) show restriction to one light chain (Kappa or Lambda)? [1].
  • [ ] Hematology Correlation: If the biopsy is monoclonal, have you been referred for a hematology evaluation to search for the “clone”? [1][8].

Common questions in this guide

Why is a kidney biopsy needed to diagnose immunotactoid glomerulopathy?
Blood and urine tests can show that the kidneys are affected, but they cannot definitively identify immunotactoid glomerulopathy. A biopsy allows a renal pathologist to examine the tissue with light microscopy, immunofluorescence, and electron microscopy when enough tissue is available.
What does electron microscopy show in immunotactoid glomerulopathy?
Electron microscopy typically shows hollow, straw-like protein structures called microtubules. They are usually about 14 to 60 nanometers wide and may be arranged in organized, parallel arrays, rather than appearing as random solid fibers.
How can pathology tell ITG apart from fibrillary disease and amyloidosis?
ITG typically has hollow, organized microtubules, a negative Congo red stain, and a negative DNAJB9 test. Fibrillary disease more often has solid, randomly arranged fibrils and positive DNAJB9, while amyloidosis usually has smaller fibrils and positive Congo red staining; the results must be interpreted together.
What does light-chain restriction mean on an ITG biopsy?
Light-chain restriction means that one antibody light chain, either kappa or lambda, is much more prominent than the other. This suggests the deposits are monoclonal, meaning they may come from one abnormal group of cells, and a hematology evaluation may be appropriate.
Which tests should be included in an ITG kidney pathology report?
A complete report should address light microscopy, immunofluorescence, and electron microscopy when sufficient tissue is available. It may also include the microtubule size and arrangement, Congo red staining, DNAJB9 testing, and whether kappa or lambda light-chain restriction is present.
How is ITG distinguished from cryoglobulinemic glomerulonephritis?
Both conditions can involve organized protein structures, so doctors may test the blood for cryoglobulins, which can clump in the cold. The pathologist also examines the patterns of deposits within the kidney's blood vessels and combines those findings with the biopsy and clinical results.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Immunotactoid glomerulopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Did the electron microscopy show hollow centers (microtubules) or solid structures (fibrils)?
  2. 2.What was the measured diameter of the microtubules in my biopsy?
  3. 3.Was my biopsy tested for the DNAJB9 protein? (A negative result supports ITG over FGN).
  4. 4.Does the immunofluorescence show 'light-chain restriction' (monoclonal)? If so, which one?
  5. 5.Did you see any 'organized arrays' or parallel stacks of these proteins, or were they arranged randomly?
  6. 6.Since Congo red staining was negative, does this argue against amyloidosis sufficiently, or do we need mass spectrometry?

References

References (8)
  1. 1

    Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants.

    Nasr SH, Kudose SS, Said SM, et al.

    Kidney international 2021; (99(2)):410-420 doi:10.1016/j.kint.2020.07.037.

    PMID: 32818517
  2. 2

    [Pathology and differential diagnosis of immunotactoid glomerulopathy].

    Sun XL, Zhang FC, Xiao Y, et al.

    Zhonghua bing li xue za zhi = Chinese journal of pathology 2016; (45(10)):703-706 doi:10.3760/cma.j.issn.0529-5807.2016.10.007.

    PMID: 27760612
  3. 3

    Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy.

    Javaugue V, Dufour-Nourigat L, Desport E, et al.

    Kidney international 2021; (99(2)):421-430 doi:10.1016/j.kint.2020.06.039.

    PMID: 32739419
  4. 4

    Glomerulopathies with Fibrillary Deposits.

    Dzekova-Vidimliski P, Karanfilovski V, Nikolov IG, et al.

    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2023; (44(2)):99-106 doi:10.2478/prilozi-2023-0030.

    PMID: 37453107
  5. 5

    [Glomerulopathies with organized monoclonal immunoglobulin deposits].

    Touchard G, Bridoux F, Goujon JM

    Nephrologie & therapeutique 2016; (12(1)):57-65.

    PMID: 26810049
  6. 6

    DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis.

    Nasr SH, Vrana JA, Dasari S, et al.

    Kidney international reports 2018; (3(1)):56-64 doi:10.1016/j.ekir.2017.07.017.

    PMID: 29340314
  7. 7

    Immunotactoid Glomerulopathy and Cryoglobulinemic Nephropathy: Two Entities with Many Similarities. A Unified Conceptual Approach.

    Herrera GA, Ojemakinde KO, Turbat-Herrera EA, et al.

    Ultrastructural pathology 2015; (39(4)):270-80 doi:10.3109/01913123.2015.1017070.

    PMID: 26270724
  8. 8

    Immunotactoid Glomerulopathy.

    Abramson M, Shaikh A

    Advances in kidney disease and health 2024; (31(4)):326-333 doi:10.1053/j.akdh.2024.03.003.

    PMID: 39084758

This page explains kidney biopsy pathology in immunotactoid glomerulopathy for informational purposes only and does not constitute medical advice. Your nephrologist and renal pathologist should interpret your report and guide your care.